MENLO PARK, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences:Cowen Annual Health Care Conference on Monday, March 1, 2021 at 1:20 p.m. ESTBarclays Global Healthcare Conference on Wednesday, March 10, 2021 at 2:25 p.m. ESTThe live... Read more
Special approval from German Federal Institute for Drugs and Medical Devices (BfArM) enables home use of a SARS-CoV-2 Rapid Antigen Test using a simple nasal swab The test will be widely available in pharmacies across Germany Basel, 26 February 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has been granted special approval... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 26, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Barclays Global Healthcare Conference on Wednesday, March 10, 2021 from 9:45 a.m. to 10:10 a.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer, will provide... Read more
WALTHAM, Mass., Feb. 26, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has completed its previously announced acquisition of Mesa Biotech, Inc., a privately held point-of-care molecular diagnostic company. “Mesa Biotech is an important part of our strategy to expand the benefits of molecular diagnostics at... Read more
CHMP has completed a review of available data for investigational antibody cocktail casirivimab and imdevimab (REGN-COV2) to be considered for the treatment of confirmed COVID-19 CHMP scientific opinion supports national decision making within EU states on the use of the antibodies before a formal authorisation is granted during a public health emergency Roche and... Read more
In two pivotal clinical studies, Evrysdi showed event-free survival and motor milestone improvements never previously achieved in the natural history of the disease More than 2,500 patients now treated with Evrysdi in clinical trial, compassionate use and real-world settings Evrysdi is approved in seven countries, submitted in 30 more Basel, 26 February 2021 – Roche... Read more
Measured more than a million collision cross sections (CCS) from whole-proteome digests of five organisms with trapped ion mobility spectrometry (TIMS) and parallel accumulation-serial fragmentation (PASEF) on several timsTOF Pro systems Large-scale CCS data from 360 LC-TIMS-MS/MS runs, processed with MaxQuant With CCS alignment, across 347,885 peptide CCS values measured in duplicate, the median coefficient... Read more
Thermo Fisher Scientific Introduces New In-line Measurement and Control System for Manufacturers of Lithium-ion Batteries Thermo Scientific LInspector measurement and control system designed to increase quality and performance of lithium-ion battery electrode coatings and separator films ERLANGEN, Germany, Feb. 25, 2021 /PRNewswire/ — The production of lithium-ion batteries is rapidly increasing, driven by the growth in... Read more
FIREFISH Part 1 data show treatment with Evrysdi at 12 months helped 90% of these infants survive without permanent ventilation and 33% sit without support, a key motor milestone not normally seen in the natural course of the disease The FDA approved Evrysdi in August 2020 as the first and only at home SMA treatment... Read more
Thermo Fisher Scientific to Present at 41st Annual Cowen Healthcare Conference on March 3, 2021 WALTHAM, Mass., Feb. 24, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 41st Annual Cowen Healthcare Conference on Wednesday,... Read more